Summit Therapeutics, Inc. (SMMT)

17.02 -1.60 (-8.62%) USD  |  NASDAQ  |  Dec 09, 16:00
17.06 +0.04 (+0.24%) After-Hours: 20:00
More

Summit Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for SMMT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
CVS Health Corp. Upgrade
UnitedHealth Group, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade